Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetesis Accelerated Registry

NCT05051228 is registered in ClinicalTrials.gov with Genetesis Inc. as lead sponsor.

NCT NCT05051228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05051228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetesis Accelerated Registry
Lead sponsor
Genetesis Inc.
Phase
Observational
Overall status
Suspended
Start date
January 27, 2021
Completion date
July 31, 2024
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, acute myocardial infarction